[go: up one dir, main page]

DE602005003907D1 - Benzothiadiazinderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die diese enthalten - Google Patents

Benzothiadiazinderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die diese enthalten

Info

Publication number
DE602005003907D1
DE602005003907D1 DE602005003907T DE602005003907T DE602005003907D1 DE 602005003907 D1 DE602005003907 D1 DE 602005003907D1 DE 602005003907 T DE602005003907 T DE 602005003907T DE 602005003907 T DE602005003907 T DE 602005003907T DE 602005003907 D1 DE602005003907 D1 DE 602005003907D1
Authority
DE
Germany
Prior art keywords
processes
preparation
pharmaceutical compositions
compositions containing
benzothiadiazine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005003907T
Other languages
English (en)
Inventor
Patrice Desos
Alexis Cordi
Pierre Lestage
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratoires Servier SAS
Original Assignee
Les Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier SAS filed Critical Les Laboratoires Servier SAS
Publication of DE602005003907D1 publication Critical patent/DE602005003907D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
DE602005003907T 2004-11-03 2005-11-02 Benzothiadiazinderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die diese enthalten Expired - Lifetime DE602005003907D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0411690A FR2877338B1 (fr) 2004-11-03 2004-11-03 Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DE602005003907D1 true DE602005003907D1 (de) 2008-01-31

Family

ID=34950935

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005003907T Expired - Lifetime DE602005003907D1 (de) 2004-11-03 2005-11-02 Benzothiadiazinderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die diese enthalten

Country Status (26)

Country Link
US (2) US7268130B2 (de)
EP (1) EP1655030B1 (de)
JP (1) JP2006151972A (de)
KR (1) KR100818431B1 (de)
CN (1) CN100396673C (de)
AR (1) AR051149A1 (de)
AT (1) ATE381338T1 (de)
AU (1) AU2005229698A1 (de)
BR (1) BRPI0504780A (de)
CA (1) CA2524859A1 (de)
DE (1) DE602005003907D1 (de)
DK (1) DK1655030T3 (de)
EA (1) EA011212B1 (de)
ES (1) ES2298970T3 (de)
FR (1) FR2877338B1 (de)
GE (1) GEP20074256B (de)
HR (1) HRP20080119T5 (de)
MA (1) MA27917A1 (de)
MX (1) MXPA05011820A (de)
NO (1) NO20055167L (de)
NZ (1) NZ543358A (de)
PL (1) PL1655030T3 (de)
PT (1) PT1655030E (de)
SG (1) SG121999A1 (de)
SI (1) SI1655030T1 (de)
ZA (1) ZA200508911B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2578224A1 (en) * 2004-08-25 2006-03-09 Essentialis, Inc. Pharmaceutical formulations of potassium atp channel openers and uses thereof
EP3545958B1 (de) * 2006-01-05 2024-07-10 Essentialis, Inc. Salze von kalium-atp-kanalöffnern und verwendungen davon
US20090062264A1 (en) * 2007-07-02 2009-03-05 Cowen Neil M Salts of potassium atp channel openers and uses thereof
US8124793B2 (en) * 2007-11-27 2012-02-28 Gail Marie Cronyn, legal representative Derivatives of ethylene methanedisulfonate as cancer chemotherapeutic agents
FR2943342B1 (fr) * 2009-03-20 2011-03-04 Servier Lab Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US20120100229A1 (en) * 2009-03-27 2012-04-26 Yale University Treatment and Prevention of White Matter Injury with KATP Channel Activators
FR2955106B1 (fr) * 2010-01-08 2011-12-23 Servier Lab Nouveaux derives de benzothiadiazines cyclopropylees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR101633632B1 (ko) 2015-09-30 2016-06-27 김동용 방사능 차폐재

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722502B1 (fr) 1994-07-12 1996-08-23 Adir Nouveau derive de benzothiadiazine, son procede depreparation et les compositions pharmaceutiques qui le contiennent
WO1998012185A1 (en) * 1996-09-17 1998-03-26 The Regents Of The University Of California Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
RU2214405C2 (ru) 1998-02-18 2003-10-20 НьюроСёрч А/С Новые соединения и их применение в качестве положительных модуляторов амра-рецепторов
FR2801587B1 (fr) * 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2833956B1 (fr) * 2001-12-21 2004-01-30 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2833950B1 (fr) * 2001-12-21 2005-12-16 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
AU2005229698A1 (en) 2006-05-18
EP1655030B1 (de) 2007-12-19
CN100396673C (zh) 2008-06-25
GEP20074256B (en) 2007-12-10
EP1655030A1 (de) 2006-05-10
NO20055167L (no) 2006-05-04
SI1655030T1 (sl) 2008-04-30
FR2877338A1 (fr) 2006-05-05
KR100818431B1 (ko) 2008-04-01
KR20060052410A (ko) 2006-05-19
FR2877338B1 (fr) 2007-01-26
ZA200508911B (en) 2006-07-26
ES2298970T3 (es) 2008-05-16
MXPA05011820A (es) 2006-05-08
DK1655030T3 (da) 2008-04-28
CA2524859A1 (fr) 2006-05-03
US20060094712A1 (en) 2006-05-04
ATE381338T1 (de) 2008-01-15
AR051149A1 (es) 2006-12-20
MA27917A1 (fr) 2006-06-01
NZ543358A (en) 2007-04-27
EA200501530A1 (ru) 2006-06-30
JP2006151972A (ja) 2006-06-15
SG121999A1 (en) 2006-05-26
NO20055167D0 (no) 2005-11-03
US20070270415A1 (en) 2007-11-22
BRPI0504780A (pt) 2006-06-27
PL1655030T3 (pl) 2008-03-31
CN1775767A (zh) 2006-05-24
PT1655030E (pt) 2008-02-08
HRP20080119T5 (en) 2008-10-31
HRP20080119T3 (en) 2008-04-30
EA011212B1 (ru) 2009-02-27
US7268130B2 (en) 2007-09-11

Similar Documents

Publication Publication Date Title
ATE473976T1 (de) Dipeptidylpeptidase-iv-inhibierende verbindungen, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese als wirkstoffe enthalten
DE602008000786D1 (de) 1,2,4,5-Tetrahydro-3H-Benzazepinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
ATE422204T1 (de) Glucopyranosyloxy-pyrazole, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
ATE557013T1 (de) Glucopyranosyl-substituierte benzol-derivate, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
EP1651651A4 (de) Cucurbiturilderivate enthaltende nanopartikel, pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung
IL169818A0 (en) Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them
DE602004011398D1 (de) Direkt komprimierbare pharmazeutische zusammensetzung für die orale verabreichung von cci-779
DE602009000873D1 (de) Diosmetin-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE602004029245D1 (de) Indolonacetamidderivate, verfahren zu deren herstellung und deren verwendungen
DE60304599D1 (de) Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE602006015062D1 (de) 3-aminocarbazolverbindungen, pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung
DE60318167D1 (de) Arzneiform und Verfahren zu ihrer Herstellung
DE60307875D1 (de) Imidazopyrin-derivate, verfahren zu ihrer herstellung and sie enthaltende pharmazeutische zusamensetzungen
ATE374172T1 (de) Hexensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon
ATE462408T1 (de) Pharmazeutische zusammensetzungen, enthaltend valatograst, und verfahren zu deren herstellung
DE602005003907D1 (de) Benzothiadiazinderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die diese enthalten
DE602005027194D1 (de) Buttersäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon
DE602006000102D1 (de) Indanyl-piperazinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE602004016015D1 (de) Benzimidazolderivate, zusammensetzungen, die diese enthalten, zubereitung davon und deren verwendungen
EP1499593A4 (de) Chinolinderivate als caspase-3-inhibitor, verfahren zu deren herstellung und pharmazeutische zusammensetzung, die diese enthält
DE602004003719D1 (de) 9-aminopodophyllotoxinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese derivate enthalten
DE502004007916D1 (de) Amidomethyl-substituierte 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro- 2h-chromen-6-yl-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ATE370927T1 (de) Pentensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und deren therapeutische anwendung
DE602004002990D1 (de) Derivate von Benzothiazin und Benzothiadiazin, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen diese enthaltend
ATE431825T1 (de) Neue antagonisten für den vitronectinrezeptor, verfahren zu deren herstellung, deren verwendung als arzneimittel und pharmazeutische zusammensetzung, die diese enthalten

Legal Events

Date Code Title Description
8332 No legal effect for de